548 Results

People

  1. Rossi
    Rossi
  2. Dee
    Dee
  3. Marghoob
    Marghoob
  4. Dogan
    Dogan
  5. Dusza
    Dusza
  6. Giralt
    Giralt
  7. Perales
    Perales
  8. Marchetti
    Marchetti
  9. Nehal
    Nehal
  10. Salles
    Salles

Groups

  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)
  7. Population Sciences Research Program (116)
  8. GSK Faculty (96)
  9. Dermatology Service (87)
  10. Dermatology (86)
  1. "Research letter"
Formats
  1. Research Letter (548)
Groups
  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)

More Groups

People
  1. Anthony Rossi (23)
  2. Edward Christopher Dee (21)
  3. Ashfaq Marghoob (19)
  4. Ahmet Dogan (18)
  5. Michael Marchetti (18)
  6. Miguel-Angel Perales (17)

More People

Years
  1. 2025 (42)
  2. 2024 (89)
  3. 2023 (101)
  4. 2022 (82)
  5. 2021 (91)
  6. 2020 (95)

More Years

Publications
  1. Journal of the American Academy of Dermatology (46)
  2. Blood Advances (31)
  3. Haematologica (25)
  4. Leukemia (25)
  5. Bone Marrow Transplantation (18)
  6. American Journal of Hematology (17)

More Publications

Publishers
  1. Nature Publishing Group (97)
  2. Mosby Elsevier (49)
  3. American Medical Association (45)
  4. American Society of Hematology (44)
  5. Wiley Blackwell (34)
  6. Elsevier Inc. (29)

More Publishers

Results (548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma
    Research Letter

    Xu, D.; Bewicke-Copley, F.; Close, K.; Okosun, J.; Gale, R. P.; Apperley, J.; Weinstock, D. M.; Wendel, H. G.; Fitzgibbon, J.
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: A real-world analysis
    Research Letter

    Epperla, N.; Zhao, Q.; Moyo, T.; Watkins, M. P.; Tavakkoli, M.; Bello, C.; Torka, P.; Reddy, N.; Thomas, C.; Annunzio, K.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Unusual gingival presentation following treatment with pembrolizumab
    Research Letter

    Singh, A.; Shem, D.; Martinez-Rubio, L.; Huryn, J. M.; Yom, S. K.; Estilo, C. L.
    Oral Oncology Reports (2024)

    Fulltext@MSK | Save
  • Oral manifestation associated with avelumab
    Research Letter

    Chung, K.; Singh, A.; Huryn, J. M.; Estilo, C. L.
    Oral Oncology Reports (2024)

    Fulltext@MSK | Save
  • Panviral metagenomic sequencing provides further evidence for human papillomavirus 42 association with digital papillary adenocarcinoma
    Research Letter

    Tekin, B.; Enninga, E. A. L.; Norgan, A. P.; Erickson, L. A.; Vanderbilt, C.; Gupta, S.; Guo, R.
    Human Pathology (2024)

    Fulltext@MSK | Save
  • Simultaneous posterior vaginal and perineal reconstruction using gluteal fasciocutaneous flaps following pelvic exenteration with sacrectomy
    Research Letter

    Pappou, E.; Ben-Yaakov, A.; Jiménez-Rodríguez, R. M.; Garcia-Aguilar, J.
    British Journal of Surgery (2024)

    Fulltext@MSK | Save
  • Gender disparities in allograft access due to HLA-sensitization in multiparous women
    Research Letter

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S.; Chinapen, S.; Scaradavou, A.; Politikos, I.; Blouin, A. G.; Shaffer, B. C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Genetics and pathologic landscape of lineage switch of acute leukemia during therapy
    Research Letter

    Zhou, T.; Curry, C. V.; Khanlari, M.; Shi, M.; Cui, W.; Peker, D.; Chen, W.; Wang, E.; Gao, J.; Shen, Q.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Impact of prior cytoreductive nephrectomy on efficacy in patients with synchronous metastatic renal cell carcinoma treated with avelumab plus axitinib or sunitinib: Post hoc analysis from the JAVELIN Renal 101 phase 3 trial
    Research Letter

    Grimm, M. O.; Oya, M.; Choueiri, T. K.; Motzer, R. J.; Schmidinger, M.; Quinn, D. I.; Gravis-Mescam, G.; Verzoni, E.; Van den Eertwegh, A. J. M.; di Pietro, A.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Trends in location of death for individuals with ovarian cancer in the United States
    Research Letter

    Mathew, A. T.; Jain, B.; Patel, T. A.; Hammond, A.; Dee, E. C.; Chino, F.
    Obstetrics and Gynecology (2024)

    Fulltext@MSK | Save